Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Unknown 2Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Colorectal Neoplasms 490Rectal Neoplasms 267Colonic Neoplasms 218Pancreatic Neoplasms 184Stomach Neoplasms 181Esophageal Neoplasms 134Breast Neoplasms 118Neoplasm Metastasis 116Squamous Cell Carcinoma of Head and Neck 94Head and Neck Neoplasms 92Neoplasms 88Adenocarcinoma Of Esophagus 67Esophageal Squamous Cell Carcinoma 61Carcinoma, Hepatocellular 54Adenocarcinoma 40Nasopharyngeal Carcinoma 33Cholangiocarcinoma 31Biliary Tract Neoplasms 26Anus Neoplasms 26Gastrointestinal Neoplasms 25Carcinoma, Squamous Cell 25Carcinoma, Non-Small-Cell Lung 25Keratosis, Actinic 22Gallbladder Neoplasms 21Urinary Bladder Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 20Liver Neoplasms 20Bile Duct Neoplasms 19Ovarian Neoplasms 16Carcinoma 16

Interventions

Paclitaxel 15atezolizumab 11Gemcitabine 11Carboplatin 9pembrolizumab 8Docetaxel 8Irinotecan 7Bevacizumab 7Injections 6Cetuximab 6Sunitinib 5Leucovorin 5Fluorouracil 5Cyclophosphamide 5Capecitabine 5tocilizumab 4olaparib 4navitoclax 4liposomal doxorubicin 4Topotecan 4Oxaliplatin 4Nivolumab 4Erlotinib Hydrochloride 4temsirolimus 3spartalizumab 3pazopanib 3lenvatinib 3fludarabine 3cobimetinib 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Solid Tumors × Fluorouracil × Clear all
NCT07415031 2026-05-15

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Mirati Therapeutics Inc.

Phase 2 Recruiting
170 enrolled
Other solid neoplasm

Solid Tumors

NCT02435927 2021-04-28

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

National Cancer Centre, Singapore

Phase 1 Unknown
60 enrolled
Other solid neoplasm

Solid Tumors

NCT02648711 2020-05-28

Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors

Lumos Pharma

Phase 1 Terminated
41 enrolled
Other solid neoplasm

Solid Tumors

NCT01634555 2019-02-26

A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI

Eli Lilly and Company

Phase 2 Completed
29 enrolled 12 charts
Other solid neoplasm

Solid Tumors

NCT03503604 2018-04-20

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

SuZhou Stainwei Biotech Inc.

Phase 1 Unknown
18 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡